1Macdonald JS,Smalley SR,Benedetti J,et al.Chemoradiofhera-py after surgery compared with surgery alone for adenocarcinomaof the stomach or gastroesophageal junction[J].N Engl J Med,2001,345(10):725-730.
2McCloskey SA,Yang GY.Benefits and challenges of radiationtherapy in gastric cancer:techniques for improving outcomes[J].Gastrointest Cancer Res,2009,3(1):15-19.
3Marks LB,Yorke ED,Jackson A,et al.Use of normal tissuecomplication probability models in the clinic[J].Int J Radiat On-col Biol Phys,2010,76(3):S10-19.
4Murthy K,Shukeili K,Kumar S,et al.Evaluation of dose cov-erage to target volume and normal tissue sparing in the adjuvantradiotherapy of gastric cancers:3D-CRT compared with dynamicIMRT[J].Biomed Imaging Interv J,2010,6(3):e29.
5Minn AY,Hsu A,La T,et al.Comparison of intensity-modula-ted radiotherapy and 3-dimensional conformal radiotherapy as ad-juvant therapy for gastric cancer[J].Cancer,2010,116(16):3943-3952.
6Beauvois S,Van Houtte P.Late effects of radiations on the kid-ney[J].Cancer Radiother,1997,1(6):760-763.
8Aunapuu M,Arend A,Ots M,et al.Cell proliferation and apop-tosis in Wistar rat kidney after renal mass ablation and low-doseirradiation[J].Medicina(Kaunas),2010,46(3):204-210.
9Diavolitsis VM,Rademaker A,Boyle J,et al.Change in creati-nine clearance over time following upper abdominal irradiation:adose-volume histogram multivariate analysis[J].Am J Clin On-col,2011,34(1):53-57.
10Lohr F,Dobler B,Mai S.Optimization of dose distributions foradjuvant locoregional radiotherapy of gastric cancer by IMRT[J].Strahlenther Onkol,2003,179(8):557-563.
